{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:59:41Z","timestamp":1786996781856,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.semradonc.2022.11.001","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T10:22:19Z","timestamp":1679912539000},"page":"193-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Radiation Therapy in the Management of Adrenal Metastases"],"prefix":"10.1016","volume":"33","author":[{"given":"Ciro","family":"Franzese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Stefanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2022.11.001_bib0001","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7","article-title":"Metastases in carcinoma. Analysis of 1000 autopsied cases","volume":"3","author":"Abrams","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0002","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.0300-0664.2001.01435.x","article-title":"Metastatic tumours of the adrenal glands: A 30-year experience in a teaching hospital","volume":"56","author":"Lam","year":"2002","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0003","doi-asserted-by":"crossref","unstructured":"Plichta K, Camden N, Furqan M, et al. SBRT to adrenal metastases provides high local control with minimal toxicity. Adv Radiat Oncol 2017;2:581-587. https:\/\/doi.org\/10.1016\/j.adro.2017.07.011","DOI":"10.1016\/j.adro.2017.07.011"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0004","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1097-0142(19900101)65:1<177::AID-CNCR2820650134>3.0.CO;2-8","article-title":"Addisonian crisis as presenting feature in malignancies","volume":"65","author":"Kung","year":"1990","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.semradonc.2022.11.001_bib0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0006","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1245\/s10434-007-9520-7","article-title":"Laparoscopic adrenalectomy for isolated adrenal metastasis","volume":"14","author":"Strong","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0007","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00268-004-7667-y","article-title":"Partial vs total adrenalectomy by the posterior retroperitoneoscopic approach: Early and long-term results of 325 consecutive procedures in primary adrenal neoplasias","volume":"28","author":"Walz","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0008","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1200\/JCO.2007.14.2091","article-title":"Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non\u2013small-cell lung cancer: A systematic review and pooled analysis","volume":"26","author":"Tanvetyanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0009","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/1097-0142(19900315)65:6<1318::AID-CNCR2820650611>3.0.CO;2-H","article-title":"Palliative radiotherapy for symptomatic adrenal metastases","volume":"65","author":"Soffen","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0010","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: Long-term results of the SABR-COMET phase II randomized trial","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0011","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00066-020-01627-7","article-title":"Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy","volume":"196","author":"Nicosia","year":"2020","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0012","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.radonc.2018.10.024","article-title":"Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapy","volume":"133","author":"Franzese","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0013","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy versus. Maintenance therapy or observation for patients with oligometastatic non\u2013small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0014","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/COC.0b013e3182569189","article-title":"Stereotactic body radiotherapy in the treatment of adrenal metastases","volume":"36","author":"Ahmed","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0015","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1007\/s00432-021-03807-z","article-title":"Phase II trial of stereotactic body radiation therapy on adrenal gland metastases: Evaluation of efficacy and impact on hormonal production","volume":"147","author":"Franzese","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0016","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7785\/tcrt.2012.500320","article-title":"Stereotactic body radiation therapy for curative treatment of adrenal metastases","volume":"12","author":"Rudra","year":"2013","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0017","first-page":"5285","article-title":"Robot-assisted extracranial stereotactic radiotherapy of adrenal metastases in oligometastatic non-small cell lung cancer","volume":"37","author":"Celik","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0018","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5301\/tj.5000222","article-title":"Evaluation of stereotactic body radiation therapy in the management of adrenal metastases from non-small cell lung cancer","volume":"101","author":"Gamsiz","year":"2015","journal-title":"Tumori J"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0019","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00066-011-2192-z","article-title":"Stereotactic Body Radiation Therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer","volume":"187","author":"Holy","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.adro.2018.05.006","article-title":"Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity","volume":"3","author":"Toesca","year":"2018","journal-title":"Adva Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0021","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200645","article-title":"Stereotactic body radiotherapy for adrenal oligometastasis in lung cancer patients","volume":"93","author":"Arcidiacono","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0022","doi-asserted-by":"crossref","unstructured":"Baydoun A, Chen H, Poon I, et al. Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study. Clin Transl Radiat Oncol 2022;33:159-164. doi:10.1016\/j.ctro.2021.09.002","DOI":"10.1016\/j.ctro.2021.09.002"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0023","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ijc.33546","article-title":"Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis","volume":"149","author":"Buergy","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0024","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00066-018-1390-3","article-title":"Fractionated stereotactic radiation therapy for adrenal metastases: Contributing to local tumor control with low toxicity","volume":"195","author":"Burjakow","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0025","article-title":"Robotic stereotactic body radiotherapy for the management of adrenal gland metastases: A bi-institutional analysis","volume":"15","author":"Ehret","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0026","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10585-021-10124-9","article-title":"Stereotactic body radiation therapy for adrenal gland metastases: Outcome and predictive factors from a multicenter analysis","volume":"38","author":"Franzese","year":"2021","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0027","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/j.prro.2016.09.005","article-title":"Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity","volume":"7","author":"Chance","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0028","doi-asserted-by":"crossref","first-page":"11563","DOI":"10.2147\/CMAR.S278781","article-title":"Hypofractionated radiotherapy for 35 patients with adrenal metastases: A single-institution experience","volume":"12","author":"Zhao","year":"2020","journal-title":"Cancer Manage Res"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0029","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818809983","article-title":"Real-time tumor-tracking radiotherapy and general stereotactic body radiotherapy for adrenal metastasis in patients with oligometastasis","volume":"17","author":"Katoh","year":"2018","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0047","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/COC.0000000000000634","article-title":"Novel dose escalation approaches for stereotactic body radiotherapy to adrenal oligometastases","volume":"43","author":"Figura","year":"2020","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0034","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ijrobp.2010.11.060","article-title":"Stereotactic radiotherapy for adrenal gland metastases: University of florence experience","volume":"82","author":"Casamassima","year":"2012","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0031","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijrobp.2008.10.079","article-title":"Stereotactic Body Radiotherapy for Treatment of Adrenal Metastases","volume":"75","author":"Chawla","year":"2009","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0046","article-title":"Stereotactic body radiation therapy (SBRT) for patients with oligometastatic\/oligoprogressive adrenal metastases: Outcomes and toxicities profile in a monoinstitutional study","volume":"29","author":"Facondo","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0037","doi-asserted-by":"crossref","unstructured":"Franzese C, Franceschini D, Cozzi L, et al. Minimally invasive stereotactical radio-ablation of adrenal metastases as an alternative to surgery. Cancer Res Treat 2017;49:20-28. https:\/\/doi.org\/10.4143\/crt.2016.057","DOI":"10.4143\/crt.2016.057"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0035","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.1120","article-title":"Robotic radiosurgery for adrenal gland metastases","author":"Haidenberger","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0033","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10585-020-10052-0","article-title":"Adrenal SBRT: a multi-institutional review of treatment outcomes and toxicity","volume":"37","author":"Helis","year":"2020","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0048","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13014-020-1480-0","article-title":"Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients","volume":"15","author":"K\u00f6nig","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0032","article-title":"Stereotactic body radiation therapy (SBRT) of adrenal gland metastases in oligometastatic and oligoprogressive disease","volume":"26","author":"Reshko","year":"2021","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0051","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3109\/0284186X.2011.652738","article-title":"Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: A retrospective analysis of 34 patients","volume":"51","author":"Scorsetti","year":"2012","journal-title":"Acta Oncologica"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00732","article-title":"Usefulness of stereotactic body radiation therapy for treatment of adrenal gland metastases","volume":"9","author":"Scouarnec","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0049","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/jcrt.JCRT_655_16","article-title":"Single institution experience treating adrenal metastases with stereotactic body radiation therapy","volume":"15","author":"Shah","year":"2019","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0036","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2217\/fon.10.165","article-title":"Stereotactic body radiation therapy for adrenal metastases: A retrospective review of a noninvasive therapeutic strategy","volume":"7","author":"Torok","year":"2011","journal-title":"Future Oncol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0050","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12885-020-07030-w","article-title":"Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases","volume":"20","author":"Voglhuber","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0052","article-title":"Clinical efficacy of stereotactic body radiation therapy (SBRT) for adrenal gland metastases: A multi-center retrospective study from China","volume":"10","author":"Zhao","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0039","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00423-011-0889-1","article-title":"Surgical management of adrenal metastases","volume":"397","author":"Sancho","year":"2012","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1464-410X.2006.05934.x","article-title":"Surgical treatment of adrenal metastasis from renal cell carcinoma: A single-centre experience of 45 patients","volume":"97","author":"Antonelli","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0041","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.radonc.2022.02.023","article-title":"Treatment patterns for adrenal metastases using surgery and SABR during a 10-year period","volume":"170","author":"van Vliet","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0042","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1148\/radiol.2311031007","article-title":"Adrenal neoplasms: CT-guided radiofrequency ablation\u2013preliminary results","volume":"231","author":"Mayo-Smith","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0043","doi-asserted-by":"crossref","unstructured":"Wood BJ, Abraham J, Hvizda JL, et al. Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 2003 Feb 1;97:554-60. https:\/\/doi.org\/10.1002\/cncr.11084","DOI":"10.1002\/cncr.11084"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0044","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s00270-008-9337-1","article-title":"Imaging-guided percutaneous radiofrequency ablation of adrenal metastases: Preliminary results at a single institution with a single device","volume":"31","author":"Carrafiello","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.semradonc.2022.11.001_bib0045","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.urology.2009.06.058","article-title":"Radio-frequency ablation of solitary adrenal gland metastasis from renal cell carcinoma","volume":"74","author":"Mouracade","year":"2009","journal-title":"Urology"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105342962200073X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105342962200073X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:53:57Z","timestamp":1760950437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105342962200073X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S105342962200073X"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2022.11.001","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy in the Management of Adrenal Metastases","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2022.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}